Filed pursuant to Rule 424(b)(5)
Registration No. 333-283353
PROSPECTUS
$25,000,000
![LOGO](https://capedge.com/proxy/424B5/0001193125-24-266176/g906765g55j57.jpg)
Class A Common Stock
Preferred Stock
Warrants
Units
The following are types of securities that we may offer, issue and sell from time to time, together or separately:
| • | | shares of our Class A common stock; |
| • | | shares of our preferred stock; |
| • | | units consisting of any combination of our Class A common stock, preferred stock and/or warrants. |
We may offer these securities in amounts, at prices, and on terms determined at the time of offering, up to an aggregate amount of $25,000,000; however, as of the date of this prospectus, under the limitations described below, we are currently only eligible to sell approximately $13.08 million of securities. We may sell these securities directly to you through agents we select or through underwriters and dealers we select. If we use agents, underwriters or dealers to sell these securities, we will name them and describe their compensation in a prospectus supplement. See “Plan of Distribution.” You should read this prospectus and any applicable prospectus supplement carefully before you invest.
This prospectus provides a general description of the securities we may offer. Each time we sell securities, we will provide specific terms of the securities offered in a supplement to this prospectus. The prospectus supplement may also add, update or change information contained in this prospectus. You should read this prospectus and the applicable prospectus supplement carefully, together with additional information described under the heading “Where You Can Find More Information,” before you invest in any securities. This prospectus may not be used to consummate a sale of securities unless accompanied by the applicable prospectus supplement.
Our Class A common stock is traded on the Nasdaq Capital Market under the symbol “BTM.” On November 11, 2024, the per share closing price of our Class A common stock as reported on the Nasdaq Capital Market was $2.68 per share.
The aggregate market value of our outstanding Class A common stock held by non-affiliates is approximately $39,250,650, which was calculated in accordance with General Instruction I.B.6 of Form S-3, based on 18,122,048 shares of Class A common stock outstanding as of November 12, 2024, of which 14,645,765 shares are held by non- affiliates, at the closing share price of $2.68 on November 11, 2024, which was the highest closing price of our Class A common stock reported on the Nasdaq Capital Market within the last 60 days prior to the date of this filing.
In this prospectus we are offering up to $25,000,000 of securities; however, pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell the securities described in this prospectus in a primary public offering with a value exceeding more than one-third of the aggregate market value of our Class A common stock held by non-affiliates in the twelve-month period prior to the date of the sale of any such securities, so long as the aggregate market value of our outstanding Class A common stock held by non-affiliates remains below $75.0 million. As of the date of this prospectus, under such rules and including our sales within the twelve-month period prior to the date of this prospectus, we are only eligible to sell up to approximately $13,083,550 of securities until our circumstances, as described above, change.
Investing in our securities involves a high degree of risk. You should review carefully the risks and uncertainties described under the heading “Risk Factors” contained in the applicable prospectus supplement and any related free writing prospectus, and under similar headings in the other documents that are incorporated by reference into this prospectus as described on page 4 of this prospectus.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
The date of this prospectus is November 26, 2024.